In yesterday’s Wall Street session, Haleon plc (NYSE:HLN) shares traded at $8.75, up 0.92% from the previous session.
As of this writing, 16 analysts cover Haleon plc (NYSE:HLN). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $10.76 and a low of $7.13, we find $9.22. Given the previous closing price of $8.67, this indicates a potential upside of 6.34 percent. HLN stock price is now 4.82% away from the 50-day moving average and 12.40% away from the 200-day moving average. The market capitalization of the company currently stands at $39.04B.
There are 5 analysts who have given it a hold rating, whereas 7 have given it a buy rating. Brokers who have rated the stock have averaged $9.08 as their price target over the next twelve months.
A total of 6.41% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HLN stock. A new stake in Haleon plc shares was purchased by HARDING LOEVNER LP during the first quarter worth $84,928,000. PALESTRA CAPITAL MANAGEMENT LLC invested $73,104,000 in shares of HLN during the first quarter. In the first quarter, LIONTRUST INVESTMENT PARTNERS LLP acquired a new stake in Haleon plc valued at approximately $18,691,000. ORION PORTFOLIO SOLUTIONS, LLC acquired a new stake in HLN for approximately $4,588,000. MARATHON PARTNERS EQUITY MANAGEMENT, LLC purchased a new stake in HLN valued at around $3,784,000 in the second quarter. In total, there are 621 active investors with 6.70% ownership of the company’s stock.
Thursday morning saw Haleon plc (NYSE: HLN) opened at $8.70. During the past 12 months, Haleon plc has had a low of $5.59 and a high of $9.05. As of last week, the company has a debt-to-equity ratio of 0.64, a current ratio of 0.90, and a quick ratio of 0.60. The fifty day moving average price for HLN is $8.35 and a two-hundred day moving average price translates $7.80 for the stock.
The latest earnings results from Haleon plc (NYSE: HLN) was released for Mar, 2023.
Moreover, the firm recently paid out its quarterly dividend on 04/27/2023. Investors who held shares on 03/17/2023 were paid a $0.0577344 dividend. On an annualized basis, this represents a $0.12 dividend and a 1.37% percent yield. There was an ex-dividend date of 03/16/2023 for this dividend.
Haleon plc(HLN) Company Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.
